MOISES ACEVEDO: Open Payments
NPI 1497199202 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,651 in 187 payments from 23 companies in 2025. Trend: 2023 $13,833 · 2024 $11,995 · 2025 $4,651
Food & beverage: $4,651
| Company | Payments | Amount |
|---|---|---|
| Botanix SB Inc | 36 | $736 |
| PFIZER INC. | 18 | $479 |
| Incyte Corporation | 21 | $424 |
| ABBVIE INC. | 15 | $421 |
| Janssen Biotech, Inc. | 14 | $341 |
| Regeneron Healthcare Solutions, Inc. | 9 | $332 |
| Amgen Inc. | 7 | $283 |
| LEO Pharma Inc. | 11 | $283 |
| UCB, Inc. | 10 | $279 |
| GENZYME CORPORATION | 5 | $162 |
Products named: SOFDRA, OPZELURA, DUPIXENT, CIBINQO, TREMFYA, Bimzelx, RINVOQ, ADBRY.
Industry payments across NY — which companies pay providers there.
